LACTOSE (INDIA)
|
The Current P/E Ratio of LACTOSE (INDIA) is 28.56.
Share Price | ₹211.5 | Jan 03,2025 |
Market Cap | ₹266.4 Cr | |
Earnings-TTM | ₹9.3 Cr | TTM-Standalone Results |
Price/Earnings | 28.56x | Calculated as Market Cap/Earnings |
---|---|---|
Explore Stock Analytics |
Definition & Calculation of PE (Price/Earnings) ratio of LACTOSE (INDIA)
P/E =
Market Capitalization
/ Net Income
or, using per-share numbers:
P/E = Stock Price /
Earnings Per Share (EPS)
Current Market Cap [ ₹266.4 Cr] as on Jan 03,2025
(/) Earnings [ ₹9.3 Cr] based on TTM-Standalone Results
(=) P/E Ratio [ 28.56x ]
Thus, for LACTOSE (INDIA) , the investors are currently willing to pay 28.56 times earnings to own 1 share of the company.
PE Multiples are the most widely used valuation multiple in practice.
Since P/E ratio uses Net Income in the calculation, P/E multiples are not always reliable for valuing companies with negative earnings.
In such cases, you may consider using Price to Book ratio or Price to Sales ratio of LACTOSE (INDIA) !
P/E ratios, also, would not adjust for differences in the capital structure between companies.
The chart below summarizes the trend in P/E Ratio of LACTOSE (INDIA) over the last five years.
Historical PE (Price/Earnings) ratio chart of LACTOSE (INDIA)
PE Ratio Performance Analysis for LACTOSE (INDIA)
- LACTOSE (INDIA) 's p/e ratio for fiscal years ending Mar2024 to Mar2020 averaged 68.02x.
- LACTOSE (INDIA) 's operated at median p/e ratio of 30.79x from fiscal years ending March 2018 to 2022.
- Looking back at the last 5 fiscal years, LACTOSE (INDIA) 's p/e ratio peaked in Mar2020 at 237.62x.
- LACTOSE (INDIA) 's p/e ratio hit its five-year low in Mar2021 of 0x.
How does LACTOSE (INDIA) 's P/E Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?
Peer Comparison (Pharmaceuticals & Drugs Industry) | Earnings-TTM (Cr) | PE Ratio | Market Cap |
---|---|---|---|
LACTOSE (INDIA) | 9.33 | 28.56 | 266.4 |
SUN PHARMACEUTICAL INDUSTRIES LTD | 11,136.50 | 39.84 | 443,661.0 |
CIPLA LTD | 4,485.22 | 27.19 | 121,970.0 |
DR REDDYS LABORATORIES LTD | 5,406.80 | 20.88 | 112,877.0 |
ZYDUS LIFESCIENCES LTD | 4,298.90 | 22.83 | 98,163.2 |
DIVIS LABORATORIES LTD | 1,836.00 | 87.42 | 160,496.0 |
MANKIND PHARMA LTD | 2,124.86 | 57.05 | 121,222.0 |
TORRENT PHARMACEUTICALS LTD | 1,802.00 | 63.86 | 115,071.0 |
LUPIN LTD | 2,651.94 | 40.74 | 108,030.0 |
AUROBINDO PHARMA LTD | 3,598.83 | 21.29 | 76,628.1 |
ABBOTT INDIA LTD | 1,284.66 | 48.75 | 62,629.8 |
Pharmaceuticals & Drugs Industry Benchmark (Top 10) PE Analysis vs LACTOSE (INDIA) 's P/E Ratio
Top 10 Industry Peers | PE Ratio |
---|---|
Min industry PE | 20.88x |
Max industry PE | 87.42x |
Median industry PE | 39.84x |
Average industry PE | 41.67x |
You may also like the below Video Courses